Korean Drug Co., Ltd. (KOSDAQ:014570)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,040.00
-20.00 (-0.49%)
At close: Feb 13, 2026
Market Cap44.08B -17.5%
Revenue (ttm)62.21B -16.4%
Net Income2.77B
EPS255.77
Shares Out10.91M
PE Ratio15.80
Forward PEn/a
Dividend160.00 (3.96%)
Ex-Dividend DateDec 29, 2025
Volume22,680
Average Volume35,904
Open4,060.00
Previous Close4,060.00
Day's Range4,000.00 - 4,060.00
52-Week Range3,940.00 - 5,470.00
Beta0.25
RSI39.33
Earnings DateFeb 23, 2026

About Korean Drug

Korean Drug Co., Ltd. manufactures and sells medicines for treating various diseases in South Korea. The company offers Medicines for urinary tract disease, digestive system, circulatory system, psychonervous system, central nervous system, respiratory system, and skin and subcutaneous system; and antivirals, antibiotics, antifungals, antipyretic, analgesis, anti-inflammatory, and other products. Korean Drug Co., Ltd. was founded in 1980 and is headquartered in Seoul, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Employees 270
Stock Exchange KOSDAQ
Ticker Symbol 014570
Full Company Profile

Financial Performance

Financial Statements